Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-25

Clinical Trial Update: Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)

View source ↗

Summary

An observational study sponsored by Vanda Pharmaceuticals aims to investigate melatonin and cortisol circadian rhythms in individuals with Smith-Magenis syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Smith Magenis Syndrome | Status: UNKNOWN